Otsuka Holdings Co., Ltd. (FRA:OS1)

Market Cap	21.64B
Revenue (ttm)	14.31B
Net Income (ttm)	2.11B
Shares Out	n/a
EPS (ttm)	3.89
PE Ratio	10.27
Forward PE	n/a
Dividend	0.71 (1.75%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	173
Open	41.00
Previous Close	40.80
Day's Range	41.00 - 41.00
52-Week Range	35.40 - 59.00
Beta	n/a
RSI	33.83
Earnings Date	Apr 30, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OS1

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY